A team of Indian scientists yesterday reported the detection of Candida auris isolates from two sampling sites on islands in the Indian Ocean—the first time the multidrug-resistant yeast has been isolated in a natural environment. The discovery was reported in mBio.
Melinta Therapeutics of Morristown, New Jersey, announced yesterday that the US Food and Drug Administration (FDA) has approved Kimyrsa (oritavancin) for treatment of adult patients with acute bacterial skin and skin-structure infections (ABSSSIs) caused by susceptible gram-positive pathogens, including methicillin-resistant Staphylococcus aureus (MRSA).
The US and UK digital COVID-19 symptom checkers consistently suggest less healthcare contact than Singapore's and Japan's, which may cause more serious outcomes, according to a study released yesterday by BMJ Health & Care Informatics.
Hospital room floors could be an underappreciated source of healthcare-associated pathogen spread, including those resistant to antibiotics, according to a study today in Infection Control and Hospital Epidemiology.
The Centers for Disease Control and Prevention (CDC) has issued new recommendations for the prevention and control of Staphylococcus aureus in neonatal intensive care unit (NICU) patients.
Data collected from Canadian acute care hospitals show significant increases in methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE) bloodstream infections (BSIs) in recent years, according to a study in the Canada Communicable Disease Report (CCDR).
The findings suggest that prevention efforts, particularly in hospitals, are yielding benefits.
A study of 150 households has found that recurrent methicillin-resistant Staphylococcus aureus skin and other soft-tissue infections (MRSA SSTIs) may be associated with persistent MRSA colonization of household members and contamination of environmental surfaces, US researchers reported yesterday in JAMA Pediatrics.
The findings question the "more is better" mantra for preventing MRSA.
Nearly a fourth of MRSA bloodstream infections were tied to injection drug use.
